Dr. Michaela Mathews is a graduate of the University of Vienna, Austria. She completed her ophthalmology residency training at UMDNJ - Robert Wood Johnson, New Jersey and her neuro-ophthalmology fellowship at the Wills Eye Hospital in Philadelphia. Dr Mathews is an expert in ischemic optic neuropathy, a disease thought to be associated with premature atherosclerosis and to precede more common manifestations of atherosclerosis, such as heart attack and stroke.
During her research fellowship at the Johns Hopkins University's Wilmer Eye Institute, she participated in groundbreaking research on the role of vascular endothelial growth factor (VEGF) and other angiogenic factors in diabetic eye disease, sickle cell retinopathy and retinopathy of prematurity. Dr. Mathews currently pursues research on ischemic optic neuropathy, age-related macular degeneration and diabetic eye disease.
In her clinical practice, Dr. Mathews applies her intimate knowledge of diabetic eye disease to treating patients at the University of Maryland Center for Diabetes and Endocrinology. She also directs and coordinates the ophthalmology consult service at University of Maryland Medical Center.